Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)

Yevgeniy Balagula, Katherine Barth Huston, Klaus J. Busam, Mario E. Lacouture, Paul B. Chapman, Patricia L. Myskowski

Research output: Contribution to journalReview article

50 Scopus citations

Fingerprint Dive into the research topics of 'Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)'. Together they form a unique fingerprint.

Medicine & Life Sciences